Siristatidis C., Dafopoulos K., Christoforidis N., Anifandis G., Pergialiotis V., Papantoniou N. (2017)
Recombinant DNA technologies have produced Corifollitropin alfa (CFa) used during IVF/ICSI in order to keep the circulating FSH levels above the threshold necessary to support multi-follicular growth for a week. In this ...